Regulatory Open Forum

 View Only
Reg Intel Conference 2024
Back to discussions
Expand all | Collapse all

Japan Drug Pricing Could Lead To Return Of Drug Lag

  • 1.  Japan Drug Pricing Could Lead To Return Of Drug Lag

    Posted 20-Jun-2022 16:07
    Historically, Japanese drug registration lagged approval in the West by a number of years. However, in the last 7 years or so, regulatory changes in Japan have expedited approval there. These changes include more drug reviewers, a simplified approval process, an updated clinical trial review process, etc. However, recently the 3 main pharmaceutical lobbies in Japan recommended that the government revise Japan's system of drug pricing to foster more drug investment and the development of new drugs. The 3 main pharmaceutical lobbies said without a more formalized pricing system, it would reduce the opportunities for the development of new drugs. There have been over 55 changes in how much drug makers can expect patients and hospitals to pay for drugs since 2014. The 3 lobbies say pricing mechanism fluctuations could lead to a renewed drug lag.

    ------------------------------
    Ames Gross
    President
    Pacific Bridge Medical
    Bethesda, MD
    www.pacificbridgemedical.com
    contact@pacificbridgemedical.com
    ------------------------------


Related Content